ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases

Clinical trial NCT05018702 · UNKNOWN

Trial details

NCT number: NCT05018702
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive, Metastatic Breast Cancer

Start date: 2021-07-14
Primary completion: 2022-12-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.